The Role of Learning in Chronic Musculoskeletal Pain
Lead Research Organisation:
University of Oxford
Department Name: Clinical Neurosciences
Abstract
Aims and objectives:
Despite its prevalence, we still don't know why some people get chronic pain, and others do not. One influential idea is that the processes in the brain that normally allow us to adapt to an injury and recover from it, are used excessively, meaning that pain is exaggerated and prolonged beyond what is necessary. This 'maladaptive brain learning' hypothesis, in its various forms, is a popular model of chronic musculoskeletal pain. However, evidence is currently limited by the lack of sufficient tools required to measure and quantify learning. The project addresses this by implementing a novel set of experimental tools based on a basic science understanding of how learning works in the brain. We will use these tools to study outcomes in two complementary longitudinal studies: i) recent onset lower back pain and ii) fibromyalgia patients embarking on a multidisciplinary treatment (MDT) program. These tools will also be disseminated openly across the APDP and further afield.
Over the last year, we have established a unique partnership with people with lived experience of pain, physiotherapists, clinicians and engineers at Oxford and Cambridge, to create a core toolkit for pain-related learning evaluation. This is a set of tablet games that people play at home. People can also use their tablet camera to record specific physio exercises which we use to reconstruct and quantify the impact of pain on movement. By using a patient-led design at the outset, the tools are user-friendly, engaging, and maximise accessibility. This provides the means to test the maladaptive learning hypothesis in a broad range of clinical cohorts.
Data to be collected:
We will pursue 3 integrated workstreams:
i) Development and dissemination of an open data analysis platform to accompany the experimental toolkit.
ii) Data collection in a cohort of 140 patients with recent onset (acute) lower back pain, presenting via NHS GP services, to predict outcomes at 12 months
iii) Data collection in a cohort of 80 patients with fibromyalgia undergoing an NHS MDT program.
Both clinical cohorts aim to look for the ability of learning metrics to predict clinical outcomes, and validate the findings with neuroimaging. All data will be made open via the ADPD datahub.
Potential benefits:
The main scientific outcome will be the identification and characterisation of how learning correlates with chronic pain outcomes. This is important because such mechanisms directly imply treatment targets, which can be realised using the non-pharmaceutical interventions (cognitive and physical rehabilitation). This therefore provides a springboard for treatment innovation across the APDP and partners.
These benefits are facilitated by the patient-led design of the tools. Practically, they are easy-to-implement, require minimal expertise, and come with open data analysis pipelines and collaborative support if required. This builds a UK-based network that will capitalise on the innovation and expertise across the whole APDP. Furthermore, the data generated by this infrastructure opens up new opportunities for bioinformatics and related applications (e.g. in clinical stratification and outcome prediction).
Legacy and sustainability.
The very nature of data collected, being based on a common set of tools, will seed a database that will grow over time. This is self-sustaining because the statistical 'power' of the database increases as more data is added, permitting comparative analyses of individual datasets to a wide-range of other conditions. The tools also provide a technological backbone that can be developed and refined over time, as new insights, tools and techniques become available. In effect once the systems are in place, they grow organically over time. This is likely to be realised in new therapies, potentially as early as 5 years, given its potential to be integrated with existing technology-based treatment methodologies.
Despite its prevalence, we still don't know why some people get chronic pain, and others do not. One influential idea is that the processes in the brain that normally allow us to adapt to an injury and recover from it, are used excessively, meaning that pain is exaggerated and prolonged beyond what is necessary. This 'maladaptive brain learning' hypothesis, in its various forms, is a popular model of chronic musculoskeletal pain. However, evidence is currently limited by the lack of sufficient tools required to measure and quantify learning. The project addresses this by implementing a novel set of experimental tools based on a basic science understanding of how learning works in the brain. We will use these tools to study outcomes in two complementary longitudinal studies: i) recent onset lower back pain and ii) fibromyalgia patients embarking on a multidisciplinary treatment (MDT) program. These tools will also be disseminated openly across the APDP and further afield.
Over the last year, we have established a unique partnership with people with lived experience of pain, physiotherapists, clinicians and engineers at Oxford and Cambridge, to create a core toolkit for pain-related learning evaluation. This is a set of tablet games that people play at home. People can also use their tablet camera to record specific physio exercises which we use to reconstruct and quantify the impact of pain on movement. By using a patient-led design at the outset, the tools are user-friendly, engaging, and maximise accessibility. This provides the means to test the maladaptive learning hypothesis in a broad range of clinical cohorts.
Data to be collected:
We will pursue 3 integrated workstreams:
i) Development and dissemination of an open data analysis platform to accompany the experimental toolkit.
ii) Data collection in a cohort of 140 patients with recent onset (acute) lower back pain, presenting via NHS GP services, to predict outcomes at 12 months
iii) Data collection in a cohort of 80 patients with fibromyalgia undergoing an NHS MDT program.
Both clinical cohorts aim to look for the ability of learning metrics to predict clinical outcomes, and validate the findings with neuroimaging. All data will be made open via the ADPD datahub.
Potential benefits:
The main scientific outcome will be the identification and characterisation of how learning correlates with chronic pain outcomes. This is important because such mechanisms directly imply treatment targets, which can be realised using the non-pharmaceutical interventions (cognitive and physical rehabilitation). This therefore provides a springboard for treatment innovation across the APDP and partners.
These benefits are facilitated by the patient-led design of the tools. Practically, they are easy-to-implement, require minimal expertise, and come with open data analysis pipelines and collaborative support if required. This builds a UK-based network that will capitalise on the innovation and expertise across the whole APDP. Furthermore, the data generated by this infrastructure opens up new opportunities for bioinformatics and related applications (e.g. in clinical stratification and outcome prediction).
Legacy and sustainability.
The very nature of data collected, being based on a common set of tools, will seed a database that will grow over time. This is self-sustaining because the statistical 'power' of the database increases as more data is added, permitting comparative analyses of individual datasets to a wide-range of other conditions. The tools also provide a technological backbone that can be developed and refined over time, as new insights, tools and techniques become available. In effect once the systems are in place, they grow organically over time. This is likely to be realised in new therapies, potentially as early as 5 years, given its potential to be integrated with existing technology-based treatment methodologies.
Technical Summary
We address whether maladaptive learning systems contribute to the maintenance of chronic pain. This has been difficult to answer because learning comprises a set of complex, interacting processes, and hence difficult to evaluate and quantify. Based on computational models of learning, we have designed a suite of tasks and analysis tools that probe domain-general value-based and sensorimotor learning. These are implemented online as a set of tablet-based computer games that can be applied easily and widely in observational or longitudinal clinical studies in domestic settings.
We will study whether learning metrics can predict clinical outcomes in: i) a longitudinal study of patients with recent onset low back pain, and ii) fibromyalgia patients undergoing an NHS MDT program. We will measure neural changes (using resting-state fMRI) and physical outcomes using a novel video-based tool to quantify movement during physiotherapy exercises.
The tools, analysis pipeline and data will all be made free and openly available to the research community. Within the APDP open Datahub, data from our and other partners can be pooled across various conditions, allowing further comprehensive characterisation of how learning is linked to chronic pain.
We adopt a systems engineering approach to the development of our tools, in which patients have and will continue to have a fundamental role in the design process itself, necessary to ensure the usability and relevance of the framework to the lived experience of pain. This builds the joint vision of researchers and patients to develop an open platform for integrated multidisciplinary evaluation and treatment.
The proposed project will have a lasting impact: building a self-sustaining data generating infrastructure focused on learning mechanisms; providing a technological platform to support innovation in non-pharmacological treatment; and building a UK pain neuroscience and engineering community focused on chronic pain
We will study whether learning metrics can predict clinical outcomes in: i) a longitudinal study of patients with recent onset low back pain, and ii) fibromyalgia patients undergoing an NHS MDT program. We will measure neural changes (using resting-state fMRI) and physical outcomes using a novel video-based tool to quantify movement during physiotherapy exercises.
The tools, analysis pipeline and data will all be made free and openly available to the research community. Within the APDP open Datahub, data from our and other partners can be pooled across various conditions, allowing further comprehensive characterisation of how learning is linked to chronic pain.
We adopt a systems engineering approach to the development of our tools, in which patients have and will continue to have a fundamental role in the design process itself, necessary to ensure the usability and relevance of the framework to the lived experience of pain. This builds the joint vision of researchers and patients to develop an open platform for integrated multidisciplinary evaluation and treatment.
The proposed project will have a lasting impact: building a self-sustaining data generating infrastructure focused on learning mechanisms; providing a technological platform to support innovation in non-pharmacological treatment; and building a UK pain neuroscience and engineering community focused on chronic pain
Publications
Desch S
(2023)
Evidence for dopaminergic involvement in endogenous modulation of pain relief.
in eLife
Hewitt D
(2025)
Tonic pain revalues associative memories of phasic pain
Katayama R
(2024)
Belief inference for hierarchical hidden states in spatial navigation.
in Communications biology
Mahajan P
(2024)
Balancing safety and efficiency in human decision making
Mancini F
(2022)
Computational and neural mechanisms of statistical pain learning.
in Nature communications
Mancini F
(2024)
Enhanced behavioural and neural sensitivity to punishments in chronic pain and fatigue
in Brain
Mancini F
(2022)
Computational and neural mechanisms of statistical pain learning.
| Description | Generative adversarial brain: a comprehensive study of multi-agent learning by natural and artificial intelligence |
| Amount | ï¿¥193,570,000 (JPY) |
| Funding ID | 22H04998 |
| Organisation | Japan Society for the Promotion of Science (JSPS) |
| Sector | Public |
| Country | Japan |
| Start | 03/2022 |
| End | 03/2027 |
| Description | Quantifying preferences for interventional neurotechnologies: a novel, co-designed, market-based evaluation tool |
| Amount | £384,521 (GBP) |
| Organisation | Advanced Research and Innovation Agency (ARIA) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2025 |
| End | 12/2026 |
| Description | APDP conference (Nottingham) |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | We presented an update of the network at the annual APDP conference in Nottingham, on 7th June 2024. |
| Year(s) Of Engagement Activity | 2024 |
| Description | BNA annual meeting: symposium - Aversive cognition and pain: from theory to neuroengineering & presenting CPNN+ |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | We jointly organised this meeting developed core concepts of computation and information processing in the pain system, towards an understanding of how this can be used to shape technological therapies. The BNA is an excellent forum to reach a large audience of UK neuroscientists, and the event was well attended in April 2023. |
| Year(s) Of Engagement Activity | 2023 |
| Description | CPNN+ Neurotechnology and Pain Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Interdisciplinary workshop that aimed to explore the promises and pitfalls of neuromodulation in chronic pain research. The workshop included morning talks across a range of translational topics that covered neuromodulation in experimental human models, methodological considerations and clinical studies. Afternoon interactive workshops focused on how to design and carry out transcranial magnetic stimulation (TMS) and transcranial ultrasound stimulation (TUS) experiments. This included guidance on how to use neuronavigation and how to integrate with EEG recordings. 56 in person attendees, attended this hybrid 2 day event at the University of Exeter in July 2024. International guest speakers, poster presentations including prizes and a workshop hosted by Brainbox. |
| Year(s) Of Engagement Activity | 2024 |
| Description | First ADPD annual conference (Nottingham) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | We presented a series of posters and a platform presentation about the CPNN+ network at the first annual APDP conference in Nottingham. The APDP is a key partner for CPNN+, as it provides a national infrastructure for chronic pain research, especially translational research. Network members also received prizes for their posters. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Immers-eXpo (Oxford) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | We co-sponsored the Oxford X-Reality Hub, in collaboration with the Jesus College Cheng Kar Shun Digital Hub, for a mixed reality expo at the University of Oxford, introducing the newest developments in mixed reality technology and its potential in research, teaching and outreach. In May 2023, we gave a platform presentation and ran a stand demonstrating our research. This was a key opportunity to reach an academic and industry audience beyond that usually interested in chronic pain. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://oxr.eng.ox.ac.uk/blog/expo_23/ |
| Description | Oxford Health BRC Pain Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This two-day hybrid conference included expert presentations and conversations about cutting-edge pain research and discussions on how the latest insights could be applied in clinical practice. The Oxford team hosted a very successful conference at Lady Margaret Hall. The meeting was organised by the NIHR Oxford Health Biomedical Research Centre (BRC), in collaboration with several other of the national BRC's and CPNN+. This brought together researchers and patients to discuss the latest progress on the development of new therapies for chronic pain. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Virtual Reality for Pain Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | This was an interdisciplinary workshop to explore the value and applicability of virtual reality and related technologies to pain. The workshop combined talks across a range of topics including the use of VR to basic and clinical pain research, insights from movement science, the design of novel XR therapies, and the integration of VR technologies and art. The workshop will followed a hybrid format, with the talks taking place in the mornings of 12-14th, and with the practical workshop on the afternoons of 12th and 13th. The event took place at Lady Margaret Hall in Oxford. Impact was achieved / measured in several ways: - The hybrid format meant we had a large number of attendees (around 120, with half online) - We selected around 20 postgraduate students/ECRs for intensive training in VR methods through a practical part of the workshop. Feedback was excellent, rated as 9.2 out of 10 overall. Several of these students are now being mentored in various ways by senior researchers - We had excellent international engagement, especially with Japan, but also through a new partnership with engineers in Nigeria. - There was significant industry interest, and this has led to several ongoing discussions about future collaborations. - The meeting was family-friendly, with childcare available and children welcomed at the social events (dinner). This was very well-received and allowed us to set a precedent for future events. Overall, this was an extremely successful event. It had been delayed because of the pandemic, but in the end it far exceeded our expectations and much of the impact is ongoing. It brought together people in a way that hadn't been done before, and as the closing event of this award, it also acted as a launch for our new EPSRC Network+ on Chronic Pain Neurotechnology, which is the key follow-on funding from this award. We are very grateful for the extension of the Versus award which allowed us to hold the workshop and get the timing right. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://sites.google.com/view/oxford-vr-workshop/home |
